A new breast cancer drug combination significantly shrunk and eliminated tumours in 28% of women tested in just 11 days. The novel treatment involves a combination of pre-chemotherapy drugs lapatinib and trastuzumab that target HER2-positive tumours.
COFFEE BREAK NEWS FOR LIFE SCIENTISTS
A pilot study set to uncover the potential of reversing type II diabetes resulted in remission of the disease in 40% of the patients taking part. The treatment involved a combination of intensive lifestyle interventions, oral medication, and insulin therapy.
British scientists developed a revolutionary method for screening cancer using breath-analyzing technology. In a preliminary study involving more than 300 patients the instrument was capable of diagnosing those with esophageal and stomach cancer with 85% accuracy.
The largest genome-wide study of baldness identified over 250 novel genetic variants involved in its onset. Male pattern baldness is a major source of anxiety and depression among men and has been linked to serious cardiovascular diseases and prostate cancer.
New study reports caffeine significantly boosts an enzyme closely involved in protection against Alzheimer´s disease and other forms of dementia. Out of 1,280 compounds tested only 24 were identified as beneficial, with caffeine at the very top of the list.
The Francis Crick Institute of London was granted permission for genome editing in human embryos in order to study the complex processes involved in early miscarriage. This is the first time a research team has ever been exempt from the ban on human testing and represents an important step forward for science.
The heated legal war over the ownership of the revolutionary CRISPR/Cas9 gene-editing technology has finally reached a verdict. The US Patent and Trademark Office (UPTO) concluded that evidence favored the Broad Institute of MIT and Harvard for most patents rather than UC Berkeley, the technology´s initial inventor.
Researchers from Harvard University announced their plan to bring the woolly mammoth back to life using CRISPR/Cas9 within two years’ time. This would not only allow us to learn more about the prehistoric behemoth, but would also represent a first step towards preservation of endangered species.
While labs are facing growing amounts of data, solutions are opening up on the global scene to help them cope with it. The change is already here. And it might be better than we expected.
Scientists developed a strain of Salmonella that fights aggressive brain cancers which produced a remarkable 20% rate of tumor remission in a rat model, where there are normally no survivors. The bacteria were genetically equipped with a sophisticated tumor-homing mechanism along with cancer fighting weapons, causing the tumors to effectively self-destruct.